Abstract:Background and Aims: Duchenne muscular dystrophy (DMD) is the most common and fatal form of muscular dystrophy. DMD-associated cardiomyopathy (DMD-CM) is a major cause of morbidity and mortality in patients with DMD. Ferroptosis, a new type of regulated cell death characterized by iron-dependence and the accumulation of cell membrane lipid peroxidation, has been manifested in various cardiovascular disease conditions. However, ferroptosis has not been studied in DMD-CM. Here, we aim to determine whether ferroptosis play a potential role in DMD-CM. Methods and Results: We used a dystrophin/utrophin double knockout (mdx:utr -/- ) mouse model that displays clinical signs of DMD and DMD-CM. We performed RNA isolation from the ventricles of 3-month-old wild type (WT) and mdx:utr -/- mice (n=3) and performed RNA-Seq analysis. We found alterations of ferroptosis-related pathways such as GTP cyclohydrolase 1, transferrin receptor, glutamine transporter SLC38A1, heme oxygenase-1 (HMOX-1), and arachidonate 5-lipoxygenase (ALOX5) pathways in mdx:utr -/- hearts compared to WT hearts. Western blots confirmed the upregulation of ALOX5 and downregulation of HMOX-1, ferroptosis suppressor protein 1, and NADPH oxidase 4 in mdx:utr -/- hearts, while there was no change in glutathione peroxidase 4 (GPX4) levels. We also observed an increased level of lipid peroxidation in mdx:utr -/- hearts compared to WT as estimated by the level of malondialdehyde. Live/dead viability assays demonstrated a higher cell death rate in cardiomyocytes from mdx:utr -/- mice (53.7±7.2%, n=24) compared to those from WT mice (11.7±1.1%, n=17, p< 0.01) under control conditions. The observed cell death in mdx:utr -/- cardiomyocytes was efficiently prevented by the selective ferroptosis inhibitor ferrostatin-1 (10 μM) (7.4±1.5%, n=9, p<0.01), but not by the apoptosis inhibitor emricasan (20 μM) (56.0±1.6%, n=3, NS). Similarly, higher death rates were also observed in mdx:utr -/- than in WT cardiomyocytes when they were treated with various ferroptosis inducers such as iron overload and the GPX4 inhibitor RSL3. Conclusion: We have deciphered the link between ferroptosis and DMD-CM for the first time. Our data suggest novel targets for the treatment of DMD-CM by inhibiting ferroptosis.

A defect in mitochondrial fatty acid synthesis impairs iron metabolism and causes elevated ceramide levels

Biallelic Mutations in the Ferredoxin Reductase Gene Cause Novel Mitochondriopathy with Optic Atrophy

Myocardial Overexpression of Mecr, A Gene of Mitochondrial Fas Ii Leads to Cardiac Dysfunction in Mouse

FARS2 Deficiency in Drosophila Reveals the Developmental Delay and Seizure Manifested by Aberrant Mitochondrial Trna Metabolism.

Glial lipid droplets and neurodegeneration in a Drosophila model of complex I deficiency

Sleep and circadian defects in a Drosophila model of mitochondrial encephalomyopathy

A Drosophila model of mitochondrial disease phenotypic heterogeneity

ETHE1 and MOCS1 deficiencies: Disruption of mitochondrial bioenergetics, dynamics, redox homeostasis and endoplasmic reticulum-mitochondria crosstalk in patient fibroblasts

CIAO1 and MMS19 deficiency: a lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders

Activation of the Keap1/Nrf2 pathway suppresses mitochondrial dysfunction, oxidative stress, and motor phenotypes in C9orf72 ALS/FTD models

Loss of the endoplasmic reticulum protein Tmem208 affects cell polarity, development, and viability

Ceramide lowering rescues respiratory defects in a Drosophila model of acid sphingomyelinase deficiency

Loss of dihydroceramide desaturase drives neurodegeneration by disrupting endoplasmic reticulum and lipid droplet homeostasis in glial cells

A Novel Interaction between MFN2/Marf and MARK4/PAR-1 Is Implicated in Synaptic Defects and Mitochondrial Dysfunction

DMT1 knockout abolishes ferroptosis induced mitochondrial dysfunction in C. elegans amyloid β proteotoxicity

Defective NADPH production in mitochondrial disease complex I causes inflammation and cell death

Mitochondrial Fatty Acid Synthesis and Mecr Regulate CD4+ T Cell Function and Oxidative Metabolism

Tissue-specific Nrf2 signaling protects against methylmercury toxicity in Drosophila neuromuscular development

Unravelling a mechanistic link between mitophagy defect, mitochondrial malfunction, and apoptotic neurodegeneration in MPS VII

Abstract P1156: Potential Role Of Ferroptosis In Duchenne Muscular Dystrophy-associated Cardiomyopathy

Characterization of the 2-Enoyl Thioester Reductase of Mitochondrial Fatty Acid Synthesis Type II in Mammals